Prashanth Tapse Sr Vp Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Successful IPOs fall on valuation worries, regulatory scrutiny

Successful IPOs fall on valuation worries, regulatory scrutiny
newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.

Prashanth tapse sr vp researchTata groupPrashanth tapseMehta equitiesMadhabi puri buchTata technologiesExicom tele systemsTrading price

Bank Nifty bearish, check where it is headed after 500-point fall

All banking indices were trading lower in the morning, a day after the Reserve Bank of India tightened the norms for personal loans and credit cards to check the unbridled growth in the unsecured loan segment

Avdhut bagkarFirst bankPrashanth tapse sr vp researchNifty bankAxis bankMehta equities ltdBank niftyReserve bankBajaj financeTechnical analystCoal indiaAsian paintsApollo hospitalsHero motocorpBank nifty outlookNifty bank today

Honasa Consumer makes muted debut: Should you buy, sell or hold Mamaearth stock?

Shares of Honasa Consumer listed at Rs 330 on the NSE and Rs 324 on the BSE, against the issue price of Rs 324

Shivani nyatiDeepinder goyalAshneer groverPrashanth tapse sr vp researchSwastika investmart ltdHonasa consumerMamaearth parent honasa consumerSwastika investmartMehta equitiesHonasa consumer ipoMamaearth ipoMamaearth newsAmaearth buy sell hold

Mamaearth IPO: Analysts cautious on Honasa Consumer shares post listing; here s what you can do now

The Rs 1,701.44 crore IPO that closed on November 2 was oversubscribed by 7.61 times

Maheshm ojhaGhazal alaghAnushi vakhariaShivani nyatiDerma coPrashanth tapse sr vp researchBusiness developmentResearch analystHonasa consumerHensex securitiesMehta equitiesSwastika investmartMamaearth ipoMamaearth ipo detailsHonasa consumerHonasa consumer shares

stock: Blue Jet Healthcare gets decent listing premium in weak market What should investors do?

It has specialized chemistry capabilities in contrast to media intermediates and high-intensity sweeteners. The company has built a long-term customer base of innovator and multi-national generic pharmaceutical companies, supported by multi-year contracts.

Shivani nyatiEtmarkets whatsappPrashanth tapse sr vp researchBlue jet healthcareJet healthcarePrashanth tapseEconomic timesBlue jet healthcare share priceBlue jet healthcare sharesBlue jet healthcare ipo